Ciatto S, Pacini P, Andreoli C, Cecchini S, Iossa A, Grazzini G, Buranelli F, Campa T, Costa A, Magni A
Centro per lo Studio e la Prevenzione Oncologica, Firenze, Italy.
Br J Cancer. 1989 Jul;60(1):102-3. doi: 10.1038/bjc.1989.229.
The authors report on 182 cases of intrathoracic metastases (ITM = lung, pleura or mediastinum) observed as first single recurrences in the course of the follow-up of patients treated for primary breast cancer. ITM were detected on standard two-views chest X-ray (CXR) at regular follow-up visits and in absence of subjective symptoms (102 A cases) or in the interval between two consecutive planned controls because of the onset of subjective symptoms (80 S cases). The average disease-free interval since primary treatment was significantly shorter in A with respect to S cases (40.3 vs. 28.5 months, P less than 0.001) as a consequence of the early detection achieved by CXR survey. On the contrary, prognosis was not influenced by ITM early diagnosis as the 10-year survival since primary treatment did not differ significantly between A or S cases (12% vs. 10%, P = 0.68). Results were confirmed on multivariate (Cox's) analysis, adjusting for potential confounders such as age or nodal status. Periodic CXR survey looks a very questionable policy as it does not seem to have any favourable impact on prognosis. Its routine use in breast cancer patients should thus be carefully reconsidered.
作者报告了182例胸内转移(ITM = 肺、胸膜或纵隔)病例,这些病例在接受原发性乳腺癌治疗的患者随访过程中被观察到为首次单发复发。ITM在定期随访的标准胸部X线双视图(CXR)检查中被发现,且当时并无主观症状(102例A组病例),或因出现主观症状而在两次连续计划检查的间隔期被发现(80例S组病例)。由于CXR检查实现了早期发现,A组病例自初次治疗后的平均无病间期相较于S组病例显著缩短(40.3个月对28.5个月,P < 0.001)。相反,ITM的早期诊断并未影响预后,因为A组或S组病例自初次治疗后的10年生存率并无显著差异(12%对10%,P = 0.68)。在对年龄或淋巴结状态等潜在混杂因素进行校正的多变量(Cox)分析中,该结果得到了证实。定期CXR检查似乎是一项很有问题的策略,因为它似乎对预后没有任何有利影响。因此,应仔细重新考虑其在乳腺癌患者中的常规应用。